The potential danger of suboptimal antibody responses in COVID-19
- PMID: 32317716
- PMCID: PMC7187142
- DOI: 10.1038/s41577-020-0321-6
The potential danger of suboptimal antibody responses in COVID-19
Abstract
There is a desperate need for effective therapies and vaccines for SARS-CoV-2 to mitigate the growing economic crisis that has ensued from societal lockdown. Vaccines are being developed at an unprecedented speed and are already in clinical trials, without preclinical testing for safety and efficacy. Yet, safety evaluation of candidate vaccines must not be overlooked.
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7187142/bin/41577_2020_321_Fig1_HTML.gif)
Similar articles
-
Rapid COVID-19 vaccine development.Science. 2020 May 29;368(6494):945-946. doi: 10.1126/science.abb8923. Epub 2020 May 8. Science. 2020. PMID: 32385100 No abstract available.
-
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.J Infect Dis. 2020 Jun 29;222(2):180-182. doi: 10.1093/infdis/jiaa234. J Infect Dis. 2020. PMID: 32365191 Free PMC article. No abstract available.
-
COVID-19 shot protects monkeys.Science. 2020 May 1;368(6490):456-457. doi: 10.1126/science.368.6490.456. Science. 2020. PMID: 32355008 No abstract available.
-
Optimizing safety surveillance for COVID-19 vaccines.Nat Rev Immunol. 2020 Aug;20(8):451-452. doi: 10.1038/s41577-020-0372-8. Nat Rev Immunol. 2020. PMID: 32555401 Free PMC article. Review.
-
Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.Front Immunol. 2020 Sep 29;11:561851. doi: 10.3389/fimmu.2020.561851. eCollection 2020. Front Immunol. 2020. PMID: 33133071 Free PMC article. Review. No abstract available.
Cited by
-
Mechanisms of antibody-dependent enhancement of infectious disease.Nat Rev Immunol. 2024 Aug 9. doi: 10.1038/s41577-024-01067-9. Online ahead of print. Nat Rev Immunol. 2024. PMID: 39122820 Review.
-
Relationship of various COVID-19 antibody titer with individual characteristics and prediction of future epidemic trend in Xiamen City, China.J Thorac Dis. 2024 Apr 30;16(4):2404-2420. doi: 10.21037/jtd-23-1516. Epub 2024 Apr 15. J Thorac Dis. 2024. PMID: 38738254 Free PMC article.
-
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection.Antibodies (Basel). 2024 Apr 3;13(2):28. doi: 10.3390/antib13020028. Antibodies (Basel). 2024. PMID: 38651408 Free PMC article. Review.
-
Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis.Sci Rep. 2024 Mar 20;14(1):6737. doi: 10.1038/s41598-024-55762-7. Sci Rep. 2024. PMID: 38509174 Free PMC article.
-
Anti-SARS-CoV-2 Antibody Response Among Spectators of Amir Cup 2020 With a History of Recovery From COVID-19 in Qatar: A Historic Cohort Study.Cureus. 2024 Feb 18;16(2):e54406. doi: 10.7759/cureus.54406. eCollection 2024 Feb. Cureus. 2024. PMID: 38505461 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous